mci 9038 has been researched along with Brain Ischemia in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.34) | 18.2507 |
| 2000's | 8 (27.59) | 29.6817 |
| 2010's | 11 (37.93) | 24.3611 |
| 2020's | 7 (24.14) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Y; He, L; Liu, Q; Wang, H; Wang, J; Xu, J; Xu, X | 1 |
| Anderson, M; Chuck, C; Feler, J; Jayaraman, MV; McTaggart, R; Moldovan, K; Poggi, J; Sweeney, J; Torabi, R | 1 |
| Alwis, I; Hofma, BR; Jackson, SP; Maclean, JAA; Samson, AL; Schoenwaelder, SM; Sturgeon, SA; Tomkins, AJ | 1 |
| Chen, HS; Cui, Y; Dai, YJ; Duan, YJ; Feng, YF; Jiang, CH; Li, GH; Liu, XD; Ma, GB; Peng, ZL; Shen, L; Sun, YL; Wang, DL; Wang, EQ; Wang, FY; Wang, K; Wang, LH; Wang, RX; Wang, YL; Yang, HP; Yang, QC; Yuan, ZM; Zhang, Y; Zhao, LW; Zhou, ZH; Zou, RL | 1 |
| Wu, T; Xu, S; Xu, Z; Zhang, W; Zhang, Y | 1 |
| Liu, P; Liu, S; Lu, H; Ma, X; Wang, L; Wang, P; Wang, Y; Zhang, F | 1 |
| Cai, D; Chen, S; He, J; Huang, P; Lai, Y; Liu, J; Sun, H; Zhou, L | 1 |
| Barreto, AD; Cai, C; Ford, GA; Grotta, JC; Pedroza, C; Rahbar, MH; Shen, L; Tyson, J | 1 |
| Barreto, AD; Grotta, JC | 1 |
| Shah, NH | 1 |
| Abe, S; Mitaki, S; Oguro, H; Onoda, K; Takayoshi, H; Yamaguchi, S | 1 |
| Ashida, S; Kojima, Y; Maezono, K; Nagakane, Y; Ogura, S; Tanaka, E; Yamamoto, Y | 1 |
| Cao, S; Chen, L; Yang, J | 1 |
| Chen, B; Lamb, J; Lei, IF; Lyden, P; Pereira, B; Rajput, P; Zhao, L | 1 |
| Cervera, A; Chamorro, Á; de la Rosa, X; Durduran, T; Justicia, C; Kristoffersen, AK; Planas, AM; Valdés, CP; Varma, HM | 1 |
| Alexandrov, AV; Balucani, C; Barlinn, K; Barreto, AD; Chen, Z; Demchuk, AM; Garami, Z; Gonzales, NR; Grotta, JC; Lee, J; Lyden, P; Martin-Schild, S; Mikulik, R; Pandurengan, R; Rahbar, MH; Savitz, SI; Shen, L; Sisson, A; Sugg, RM; Tsivgoulis, G; Wu, TC | 1 |
| Kumagai, N; Nagao, T; Okuhara, Y; Origasa, H; Takekawa, H; Yamaguchi, T | 1 |
| Alexandrov, AV; Bavarsad Shahripour, R | 1 |
| LaMonte, MP | 1 |
| Aoki, T; Matsuoka, N; Mihara, K; Moriguchi, A; Mutoh, S; Tojo, N | 1 |
| LaMonte, MP; Stallmeyer, MJ | 1 |
| Brown, PM; Hursting, MJ; LaMonte, MP | 1 |
| Nishimura, S; Nishino, A; Numagami, Y; Sakurai, Y; Suzuki, H; Suzuki, I; Suzuki, S; Uenohara, H; Utsunomiya, A | 1 |
| Haines, ST; Hursting, MJ; LaMonte, MP; Mikdashi, JA; Patterson, SL | 1 |
| Kario, K; Kodama, K; Koide, M; Matsuo, T | 1 |
| Kawai, H; Sugimoto, J; Tamao, Y; Yuki, S | 1 |
| Akiguchi, I; Tomimoto, H | 1 |
| Berens, KL; Brown, PM; Chopp, M; Lu, M; Morris, DC; Zhang, L; Zhang, ZG | 1 |
| Jin, YJ; Mima, T; Park, KC; Raicu, V; Shimizu, K | 1 |
6 review(s) available for mci 9038 and Brain Ischemia
| Article | Year |
|---|---|
Ancillary approaches to plasminogen activators.
Topics: Anticoagulants; Arginine; Brain Ischemia; Cerebral Hemorrhage; Clinical Trials as Topic; Collateral Circulation; Drug Synergism; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Hypothermia, Induced; Low-Level Light Therapy; Pipecolic Acids; Plasminogen Activators; Platelet Aggregation Inhibitors; Prospective Studies; Recombinant Proteins; Sulfonamides; Thrombolytic Therapy; Tirofiban; Tyrosine; Ultrasonic Therapy; Vasodilator Agents | 2012 |
Argatroban in thrombotic stroke.
Topics: Animals; Anticoagulants; Arginine; Brain Ischemia; Collateral Circulation; Humans; Pipecolic Acids; Stroke; Sulfonamides; Thrombin; Thrombosis | 2002 |
Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor.
Topics: Anticoagulants; Arginine; Brain Ischemia; Clinical Trials as Topic; Dose-Response Relationship, Drug; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Risk Factors; Sulfonamides; Thrombin; Thrombocytopenia | 2005 |
[Nontraumatic arterial dissection of the anterior cerebral artery: six cases report].
Topics: Adult; Aged; Anterior Cerebral Artery; Anticoagulants; Aortic Dissection; Arginine; Brain Ischemia; Cerebral Angiography; Female; Humans; Hypertension; Infarction, Anterior Cerebral Artery; Intracranial Aneurysm; Magnetic Resonance Imaging; Male; Middle Aged; Pipecolic Acids; Prognosis; Subarachnoid Hemorrhage; Sulfonamides | 2005 |
Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Azathioprine; Brain Ischemia; Dexamethasone; Humans; Male; Middle Aged; Pipecolic Acids; Stroke; Sulfonamides; Warfarin | 2006 |
[The role of immunologic reactions in the pathogenesis in Binswanger's disease; a clue to therapeutic approach].
Topics: Animals; Antithrombins; Arginine; Blood Coagulation Factors; Brain; Brain Ischemia; Cyclosporine; Dementia, Vascular; Humans; Immunosuppressive Agents; Neuroglia; Pipecolic Acids; Sulfonamides; Thrombin | 1999 |
5 trial(s) available for mci 9038 and Brain Ischemia
| Article | Year |
|---|---|
Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial.
Topics: Aged; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Ischemic Stroke; Male; Stroke; Tissue Plasminogen Activator; Treatment Outcome | 2023 |
Argatroban Increased the Basal Vein Drainage and Improved Outcomes in Acute Paraventricular Ischemic Stroke Patients.
Topics: Aged; Antithrombins; Arginine; Blood Flow Velocity; Brain Ischemia; Cerebral Veins; Drainage; Drug Therapy, Combination; Female; Humans; Ischemic Stroke; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Tissue Plasminogen Activator | 2020 |
Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).
Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Brain Ischemia; Cerebral Hemorrhage; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pipecolic Acids; Severity of Illness Index; Stroke; Sulfonamides; Tissue Plasminogen Activator | 2017 |
Prognostic significance of smoking in patients with acute ischemic stroke within 3 months of onset.
Topics: Aged; Aged, 80 and over; Antipyrine; Arginine; Brain Ischemia; Chi-Square Distribution; Disability Evaluation; Drug Therapy, Combination; Edaravone; Female; Fibrinolytic Agents; Humans; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pipecolic Acids; Recovery of Function; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Stroke; Sulfonamides; Time Factors; Treatment Outcome | 2013 |
Thrombin inhibition in the acute phase of ischaemic stroke using argatroban.
Topics: Aged; Antithrombins; Arginine; Brain Ischemia; Double-Blind Method; Female; Fibrin Fibrinogen Degradation Products; Glycerol; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Placebos; Reference Values; Sulfonamides; Thrombin; Thromboplastin | 1995 |
18 other study(ies) available for mci 9038 and Brain Ischemia
| Article | Year |
|---|---|
Dual Antiplatelet Therapy Plus Argatroban Prevents Early Neurological Deterioration in Branch Atherosclerosis Disease.
Topics: Arginine; Aspirin; Atherosclerosis; Brain Ischemia; Clopidogrel; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Stroke; Sulfonamides; Ticlopidine | 2022 |
Dual antiplatelet use in the management of COVID-19 associated acute ischemic stroke reocclusion.
Topics: Aspirin; Brain Ischemia; COVID-19; Humans; Ischemic Stroke; Middle Aged; Retrospective Studies; SARS-CoV-2; Stroke; Thrombectomy; Ticagrelor; Treatment Outcome | 2023 |
Development of a carotid artery thrombolysis stroke model in mice.
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Brain Ischemia; Carotid Artery, Common; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mice; Pipecolic Acids; Stroke; Sulfonamides; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2022 |
Efficacy and Prognosis of Adjuvant Argatroban Treatment in Acute Ischemic Stroke Patients with Early Neurological Deterioration.
Topics: Aspirin; Brain Ischemia; Humans; Ischemic Stroke; Prognosis; Stroke; Treatment Outcome | 2023 |
Early and long-term outcomes of argatroban use in patients with acute noncardioembolic stroke.
Topics: Aged; Arginine; Brain Ischemia; Endovascular Procedures; Female; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Sulfonamides; Treatment Outcome | 2020 |
Response by Barreto and Grotta to Letter Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)".
Topics: Arginine; Brain Ischemia; Fibrinolytic Agents; Humans; Pipecolic Acids; Recombinant Proteins; Stroke; Sulfonamides; Tissue Plasminogen Activator; Treatment Outcome | 2017 |
Letter by Shah Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)".
Topics: Arginine; Brain Ischemia; Fibrinolytic Agents; Humans; Pipecolic Acids; Recombinant Proteins; Stroke; Sulfonamides; Tissue Plasminogen Activator; Treatment Outcome | 2017 |
Retrospective Analysis of Argatroban in 353 Patients with Acute Noncardioembolic Stroke.
Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Male; Methacrylates; Middle Aged; Pipecolic Acids; Prognosis; Retrospective Studies; Severity of Illness Index; Stroke; Sulfonamides | 2018 |
[Safety of Dual Antiplatelet Therapy with Argatroban in Patients with Acute Ischemic Stroke].
Topics: Arginine; Brain Ischemia; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Sulfonamides | 2018 |
Argatroban plus aspirin versus aspirin in acute ischemic stroke.
Topics: Arginine; Aspirin; Brain Ischemia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Severity of Illness Index; Statistics as Topic; Stroke; Sulfonamides; Treatment Outcome | 2018 |
Direct thrombin inhibitor argatroban reduces stroke damage in 2 different models.
Topics: Animals; Arginine; Brain; Brain Ischemia; Learning Curve; Male; Maze Learning; Pipecolic Acids; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Stroke; Sulfonamides; Thrombin | 2014 |
Mannose-binding lectin promotes local microvascular thrombosis after transient brain ischemia in mice.
Topics: Animals; Antithrombins; Arginine; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Fibrinogen; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Mannose-Binding Lectin; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Pipecolic Acids; Reperfusion Injury; Sulfonamides; Thrombosis | 2014 |
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Brain Ischemia; Cerebral Arteries; Cerebral Hemorrhage; Cerebral Veins; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pilot Projects; Pipecolic Acids; Stroke; Sulfonamides; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2012 |
Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban.
Topics: Animals; Antithrombins; Arginine; Blood Coagulation; Blood Platelets; Brain Ischemia; Disease Models, Animal; Guinea Pigs; Infarction, Middle Cerebral Artery; Male; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Sulfonamides; Thromboxane B2 | 2004 |
Acute ischemic stroke successfully treated using sequenced intravenous and intra-arterial thrombolysis and argatroban anticoagulation: a case study.
Topics: Acute Disease; Adult; Anticoagulants; Arginine; Brain Ischemia; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Pipecolic Acids; Stroke; Sulfonamides | 2004 |
Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.
Topics: Animals; Antithrombins; Arginine; Brain Ischemia; Cerebral Arteries; Disease Models, Animal; Male; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides | 1996 |
Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
Topics: Animals; Antithrombins; Arginine; Brain Ischemia; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Fibrin; Incidence; Infarction, Middle Cerebral Artery; Intracranial Embolism; Male; Pipecolic Acids; Rats; Rats, Wistar; Recombinant Proteins; Stroke; Sulfonamides; Time Factors; Tissue Plasminogen Activator | 2001 |
Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils.
Topics: Animals; Anticoagulants; Antipyrine; Arginine; Body Water; Brain Edema; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Drug Interactions; Drug Therapy, Combination; Edaravone; Endothelium, Vascular; Free Radical Scavengers; Free Radicals; Gerbillinae; Male; Nerve Degeneration; Neuroprotective Agents; Pipecolic Acids; Prosencephalon; Reperfusion Injury; Sulfonamides | 2002 |